/Investor DB

Health Velocity Capital — 2025 Investments

5 investments dated 2025 · listed companies and verified rows first · show all

Arteraartera.aiin𝕏Dec 2025 · $150M

Artera develops AI-powered diagnostic tests that analyze patient biopsy images to predict therapeutic response in cancer care.

AI & Machine LearningHealthtechMedical DevicesLos Altos, US

Andre Esteva(Founder)in

Co-investorsAIspace VenturesBreyer CapitalCoatue ManagementKoch Disruptive TechnologiesLead Edge CapitalStartX+8 more

Arteraartera.ioin𝕏Dec 2025 · $150M

Artera provides AI-powered voice and text communication agents for healthcare providers to improve patient engagement and streamline coordination of care.

AI & Machine LearningDigital HealthHealthtechSaaSSanta Barbara, US

Guillaume de Zwirek(CEO and Co-founder)in

Co-investorsJackson Square VenturesMartin VenturesMemorialCare Innovation FundScOp Venture CapitalTechstarsHeritage Medical Systems+2 more

Surecosureco.cominSeries A · Sep 2025 · $23M

SureCo administers Individual Coverage Health Reimbursement Arrangements (ICHRA) exclusively for large employer groups, offering an enrollment platform, HRIS integrations, direct carrier payments, and managed open enrollment.

HealthtechInsurTechSaaS

Matt Christopherson(Co-Founder)inMatthew Kim(CEO)inRobert Horry(Chief Impact Officer)

BoardMarc Bablot(Founding Board Member)

Co-investorsKaiser Permanente Ventures

Torchtorch.idJan 2025 · $17M

Torch provides merchandise production and fulfillment services for online communities, handling design, production, and logistics so community creators can generate revenue without managing operations.

ConsumerCreator EconomyDirect to ConsumerE-commerceMarketplacesBandung, ID

Ben WirawanHanafi Salman

Co-investorsInit 6137 VenturesAlumni VenturesAmex VenturesBessemer Venture PartnersNorwest Venture Partners+2 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Greater Good Healthcare Inc.

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.